84 related articles for article (PubMed ID: 21821302)
1. Residual DNA double strand breaks in perfused but not in unperfused areas determine different radiosensitivity of tumours.
Menegakis A; Eicheler W; Yaromina A; Thames HD; Krause M; Baumann M
Radiother Oncol; 2011 Jul; 100(1):137-44. PubMed ID: 21821302
[TBL] [Abstract][Full Text] [Related]
2. The extreme radiosensitivity of the squamous cell carcinoma SKX is due to a defect in double-strand break repair.
Kasten-Pisula U; Menegakis A; Brammer I; Borgmann K; Mansour WY; Degenhardt S; Krause M; Schreiber A; Dahm-Daphi J; Petersen C; Dikomey E; Baumann M
Radiother Oncol; 2009 Feb; 90(2):257-64. PubMed ID: 19038467
[TBL] [Abstract][Full Text] [Related]
3. Prediction of clonogenic cell survival curves based on the number of residual DNA double strand breaks measured by gammaH2AX staining.
Menegakis A; Yaromina A; Eicheler W; Dörfler A; Beuthien-Baumann B; Thames HD; Baumann M; Krause M
Int J Radiat Biol; 2009 Nov; 85(11):1032-41. PubMed ID: 19895280
[TBL] [Abstract][Full Text] [Related]
4. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation.
Yaromina A; Krause M; Thames H; Rosner A; Krause M; Hessel F; Grenman R; Zips D; Baumann M
Radiother Oncol; 2007 Jun; 83(3):304-10. PubMed ID: 17517444
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant inhibition of the epidermal growth factor receptor after fractionated irradiation of FaDu human squamous cell carcinoma.
Krause M; Hessel F; Zips D; Hilberg F; Baumann M
Radiother Oncol; 2004 Jul; 72(1):95-101. PubMed ID: 15236881
[TBL] [Abstract][Full Text] [Related]
6. Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?
Yaromina A; Hölscher T; Eicheler W; Rosner A; Krause M; Hessel F; Petersen C; Thames HD; Baumann M; Zips D
Radiother Oncol; 2005 Aug; 76(2):206-12. PubMed ID: 16024121
[TBL] [Abstract][Full Text] [Related]
7. Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice.
Schütze C; Bergmann R; Yaromina A; Hessel F; Kotzerke J; Steinbach J; Baumann M; Beuthien-Baumann B
Radiother Oncol; 2007 Jun; 83(3):311-5. PubMed ID: 17502117
[TBL] [Abstract][Full Text] [Related]
8. Residual gammaH2AX foci in head and neck squamous cell carcinomas as predictors for tumour radiosensitivity: Evaluation in pre-clinical xenograft models and clinical specimens.
Meneceur S; Löck S; Gudziol V; Hering S; Bütof R; Rehm M; Baumann M; Krause M; von Neubeck C
Radiother Oncol; 2019 Aug; 137():24-31. PubMed ID: 31048234
[TBL] [Abstract][Full Text] [Related]
9. Residual γH2AX foci predict local tumour control after radiotherapy.
Koch U; Höhne K; von Neubeck C; Thames HD; Yaromina A; Dahm-Daphi J; Baumann M; Krause M
Radiother Oncol; 2013 Sep; 108(3):434-9. PubMed ID: 23891089
[TBL] [Abstract][Full Text] [Related]
10. EGFR-TK inhibition before radiotherapy reduces tumour volume but does not improve local control: differential response of cancer stem cells and nontumourigenic cells?
Krause M; Prager J; Zhou X; Yaromina A; Dörfler A; Eicheler W; Baumann M
Radiother Oncol; 2007 Jun; 83(3):316-25. PubMed ID: 17531334
[TBL] [Abstract][Full Text] [Related]
11. Effect of the hypoxic cell sensitizer isometronidazole on local control of two human squamous cell carcinomas after fractionated irradiation.
Schreiber A; Krause M; Zips D; Dörfler A; Richter K; Vettermann S; Petersen C; Beuthien-Baumann B; Thümmler D; Baumann M
Strahlenther Onkol; 2004 Jun; 180(6):375-82. PubMed ID: 15175873
[TBL] [Abstract][Full Text] [Related]
12. Tumour-infiltrating CD11b+ myelomonocytes and response to fractionated irradiation of human squamous cell carcinoma (hSCC) xenografts.
Zaleska K; Bruechner K; Baumann M; Zips D; Yaromina A
Radiother Oncol; 2011 Oct; 101(1):80-5. PubMed ID: 21724288
[TBL] [Abstract][Full Text] [Related]
13. Impact of the tumour bed effect on microenvironment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse.
Zips D; Eicheler W; Brüchner K; Jackisch T; Geyer P; Petersen C; van der Kogel AJ; Baumann M
Int J Radiat Biol; 2001 Dec; 77(12):1185-93. PubMed ID: 11747543
[TBL] [Abstract][Full Text] [Related]
14. γH2AX assay in ex vivo irradiated tumour specimens: A novel method to determine tumour radiation sensitivity in patient-derived material.
Menegakis A; von Neubeck C; Yaromina A; Thames H; Hering S; Hennenlotter J; Scharpf M; Noell S; Krause M; Zips D; Baumann M
Radiother Oncol; 2015 Sep; 116(3):473-9. PubMed ID: 25866027
[TBL] [Abstract][Full Text] [Related]
15. Tumor heterogeneity determined with a γH2AX foci assay: A study in human head and neck squamous cell carcinoma (hHNSCC) models.
Rassamegevanon T; Löck S; Range U; Krause M; Baumann M; von Neubeck C
Radiother Oncol; 2017 Sep; 124(3):379-385. PubMed ID: 28739384
[TBL] [Abstract][Full Text] [Related]
16. Radiosensitization of tumour cell lines by the polyphenol Gossypol results from depressed double-strand break repair and not from enhanced apoptosis.
Kasten-Pisula U; Windhorst S; Dahm-Daphi J; Mayr G; Dikomey E
Radiother Oncol; 2007 Jun; 83(3):296-303. PubMed ID: 17521756
[TBL] [Abstract][Full Text] [Related]
17. Response of human squamous cell carcinoma xenografts of different sizes to irradiation: relationship of clonogenic cells, cellular radiation sensitivity in vivo, and tumor rescuing units.
Baumann M; Dubois W; Suit HD
Radiat Res; 1990 Sep; 123(3):325-30. PubMed ID: 2145606
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of DNA double-strand breaks in normal tissues after fractionated irradiation.
Rübe CE; Fricke A; Wendorf J; Stützel A; Kühne M; Ong MF; Lipp P; Rübe C
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1206-13. PubMed ID: 20206019
[TBL] [Abstract][Full Text] [Related]
19. Recovery from sublethal damage during fractionated irradiation of human FaDu SCC.
Petersen C; Zips D; Krause M; Völkel W; Thames HD; Baumann M
Radiother Oncol; 2005 Mar; 74(3):331-6. PubMed ID: 15763315
[TBL] [Abstract][Full Text] [Related]
20. Combined treatment of the immunoconjugate bivatuzumab mertansine and fractionated irradiation improves local tumour control in vivo.
Gurtner K; Hessel F; Eicheler W; Dörfler A; Zips D; Heider KH; Krause M; Baumann M
Radiother Oncol; 2012 Mar; 102(3):444-9. PubMed ID: 22100655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
